Evidence map›Paper›PMID 25105949›Full record

ArticleInflammatory bowel diseases2014

The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases.

Lori M Gawron, Adina Goldberger, Andrew J Gawron, Cassing Hammond, Laurie Keefer

Open access · bronzeAbstract read
In one paragraph

Article in Inflammatory bowel diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. High Use of Estrogen-based Contraceptives in Young Women With Inflammatory Bowel Disease in the United States.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024
    Article
  6. Article
  7. [How Should We Do Different Approach to Treat Inflammatory Bowel Disease by Gender Difference?]The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2021
    Review
  8. Correlation of menstrual distress to severity of gastrointestinal symptoms in inflammatory bowel disease patients.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2020
    Article
  9. Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2020
    Article
  10. Article
  11. Change in bowel habits during menstruation: are IBD patients different?Therapeutic advances in gastroenterology · 2020
    Article
  12. Article
  13. Updates on Women's Health Issues in Patients with Inflammatory Bowel Disease.Current treatment options in gastroenterology · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Sex-Specific Issues in Inflammatory Bowel Disease.Gastroenterology & hepatology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lori M Gawron*Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois; †Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; and ‡Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Adina Goldberger
Andrew J Gawron
Cassing Hammond
Laurie Keefer
Northwestern University · US

Funding

Research Career Development in Obstetrics and GynecologyK12HD050121 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Serdar E. Bulun · 2005 to 2026
$7.2M
NICHD NIH HHS K12 HD050121
6 · The paper itself

Abstract

backgroundWomen with inflammatory bowel diseases (IBD) commonly report an increase in their IBD symptoms related to their menstrual cycle. Hormonal contraceptives are safe for women with IBD and frequently used for reproductive planning, but data are lacking on their effect on IBD-related symptoms.

methodsWe completed a cross-sectional phone survey of 129 women (31% response rate), aged 18 to 45 years, with IBD in an academic practice between March and November 2013. An electronic database query identified eligible women, and we sent an opt-out letter before contact. Questions included demographics, medical and reproductive history, and current/previous contraceptive use. Women were asked if/how their menses affected IBD-related symptoms and if/how their contraceptive affected symptoms. We calculated descriptive statistics and made comparisons by Crohn's disease versus ulcerative colitis on Stata V11.

resultsParticipants were predominately white (85%) and college educated (97%), with a mean age of 34.2 (SD 6.2, range 19-45) years. Sixty percent had Crohn's disease, and 30% had IBD-related surgery previously. Half of the participants were parous, and 57% desired future pregnancy. Of the participants, 88% reported current or past hormonal contraceptive use and 60% noted cyclical IBD symptoms. Symptomatic improvement in cyclical IBD symptoms was reported by 19% of estrogen-based contraceptive users and 47% of levonorgestrel intrauterine device users. Only 5% of all hormonal method users reported symptomatic worsening.

conclusionsIn a subset of women with IBD, 20% of hormonal contraception users reported improved cyclical menstrual-related IBD symptoms. Health care providers should consider potential noncontraceptive benefits of hormonal contraception in women with cyclical IBD symptoms.

Indexed as

AdultColitis, UlcerativeContraceptives, Oral, HormonalCrohn DiseaseCross-Sectional StudiesFemaleFollow-Up StudiesHumansMenstrual CycleMiddle AgedPregnancyPrognosisYoung AdultContraceptives, Oral, Hormonal

Identifiers

PMID25105949
PMCPMC8449542
OpenAlexW2049157930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.